# 74 - 188 Endemic Treponematoses

### 188 Endemic Treponematoses

Rates of decline of serologic titers appear to be slower, and serologi­
cally defined treatment failures more common among HIV-infected 
patients than among those without HIV co-infection; however, 
effective ART may reduce these differences. Re-treatment should 
be considered if serologic responses are not adequate or if clinical 
signs persist or recur. The CSF may be examined, with treatment 
for neurosyphilis if CSF is abnormal and treatment for late latent 
syphilis if CSF is normal. Patients treated for late latent syphilis 
frequently have low initial VDRL or RPR titers and may not have 
a fourfold decline after therapy with penicillin. In such patients, 
re-treatment is not warranted unless the titer rises or signs and 
symptoms of syphilis appear. Because treponemal tests may remain 
reactive despite treatment for seropositive syphilis, these tests are 
not useful in following the response to therapy.

The activity of neurosyphilis (symptomatic or asymptomatic) 
correlates best with CSF pleocytosis, and this measure provides the 
most sensitive index of response to treatment. Repeat CSF exami­
nations may be performed every 6 months until the cell count is 
normal. An elevated CSF cell count falls to normal in 3–12 months 
in adequately treated HIV-uninfected patients. The persistence of 
mild pleocytosis in HIV-infected patients may be due to the pres­
ence of HIV in CSF; this scenario may be difficult to distinguish 
from treatment failure. Elevated levels of CSF protein fall more 
slowly, and the CSF VDRL titer declines gradually over several 
years. In patients treated for neurosyphilis, a fourfold reduction in 
serum RPR titer has been positively correlated with normalization 
of CSF abnormalities; this correlation is stronger in HIV-uninfected 
patients and in HIV-infected patients receiving effective ART. 
Thus, multiple follow-up CSF examinations may not be necessary 
in patients treated for neurosyphilis in whom serologic titers are 
falling appropriately.
PART 5
Infectious Diseases
IMMUNITY TO SYPHILIS
The rate of development of acquired resistance to T. pallidum after nat­
ural or experimental infection depends on both the size of the infecting 
inoculum and the duration of infection before treatment. Both humoral 
and cellular responses are important in the healing of early lesions. Cel­
lular infiltration, predominantly by T lymphocytes and macrophages, 
produces an interferon γ–dominated cytokine milieu and results in the 
clearance of organisms by activated macrophages. Specific antibod­
ies to surface antigens enhance phagocytosis. Antigenic variation of 
the TprK protein contributes to development of subsequent stages of 
syphilis, persistence of infection, and susceptibility to reinfection with 
another strain. Comparative genomic studies have revealed genes with 
sequence variations among T. pallidum strains, leading to development 
of molecular typing methods used to examine syphilis outbreaks. Sev­
eral laboratories are actively working to develop effective vaccines that 
stimulate the relevant protective immunologic functions to attenuate or 
prevent lesion development and reduce dissemination of T. pallidum to 
distant anatomic sites.
■
■FURTHER READING
Hamill M et al: State of the art review: Neurosyphilis. Clin Infect Dis 
78:e57, 2024. 
Luetkemeyer A et al: Postexposure doxycycline to prevent bacterial 
sexually transmitted infections. N Engl J Med 388:1296, 2023.
Lukehart S et al: Immunization with a tri-antigen syphilis vaccine 
significantly attenuates chancre development, reduces bacterial load, 
and inhibits dissemination of T. pallidum. Vaccine 40:7676, 2022.
Tantalo L et al: Antimicrobial susceptibility of Treponema pallidum 
subspecies pallidum: An in-vitro study. Lancet Microbe 4:e994, 

2023.
Workowski K et al: Sexually transmitted infections treatment guide­
lines, 2021. MMWR Recomm Rep 70:39, 2021.

Sheila A. Lukehart, Lorenzo Giacani

Endemic Treponematoses
The endemic treponematoses are chronic diseases that are generally trans­
mitted by direct contact, usually during childhood and, like syphilis, can 
cause severe late manifestations years after initial infection. These diseases 
are caused by spirochete bacteria closely related to Treponema pallidum 
subspecies pallidum, the etiologic agent of syphilis (Chap. 187). Yaws, 
pinta, and bejel (endemic syphilis) have traditionally been distinguished 
from venereal syphilis by mode of transmission, age of acquisition, geo­
graphic distribution, and clinical features; however, there is overlap for 
each of these factors. Most of our “knowledge” about these infections is 
based on observations by health care workers who have visited endemic 
areas during the past 70 years. Except for the ongoing programs of mass 
drug administration (MDA) for yaws eradication promoted by the World 
Health Organization (WHO), virtually no well-designed studies of the 
natural history, diagnosis, or treatment of these infections have been 
conducted. The four classically defined treponemal infections, modified 
by current knowledge, are compared in Table 188-1.
■
■EPIDEMIOLOGY
Generally, yaws flourishes in moist tropical areas (Fig. 188-1); bejel has 
been found primarily in arid climates of West Africa and the Middle 
East; and pinta has been found in temperate foci in the Americas. 
Because of the ongoing yaws eradication programs, some survey data 
are available for that disease, but no epidemiologic data are available for 
bejel and pinta, aside from sparse case reports. Thus, the current extent 
of these infections is unknown. The endemic treponematoses have 
traditionally been limited to rural areas of developing nations and have 
been seen in developed countries primarily among recent immigrants 
from endemic regions.
In a WHO-sponsored mass eradication campaign from 1952 to 
1969, >160 million people in Africa, Asia, and South America were 
examined for treponemal infections, and >50 million cases, contacts, 
and persons with latent infections were treated. This campaign reduced 
the prevalence of active yaws from >20% to <1% in many areas. In sub­
sequent decades, lack of focused surveillance and diversion of resources 
resulted in the documented resurgence of these infections in some 
regions. Of nearly 100 countries previously endemic for yaws, there are 
16 countries with reported yaws cases during 2017–2022, and 3 others 
with suspected cases; there are no data for the remaining countries. In 
2022, a total of 168,239 suspected cases were reported, primarily from 
Papua New Guinea, Côte d’Ivoire, Ghana, and Solomon Islands, all 
countries in which focused or integrated yaws detection programs and 
treatment trials are ongoing. Other areas of resurgent yaws morbidity 
in Africa include Cameroon, Togo, Benin, Central African Republic, 
Nigeria, Congo, Liberia, and Democratic Republic of the Congo. In 
Asia and the Pacific Islands, reports document active cases of yaws in 
Papua New Guinea, the Solomon Islands, Timor Leste, Vanuatu, the 
Philippines, and Indonesia. After years of focused programs, India was 
declared yaws-free in 2016. In the Americas, suspected yaws cases have 
been reported in Haiti, Colombia, and Ecuador, with no recent data for 
Peru, Brazil, Guyana, Suriname, and many Caribbean islands.
The prevalence of bejel is estimated to be >10% in some regions of 
northern Ghana, Mali, Niger, Burkina Faso, and Senegal, although data 
are scarce. No data are available from formerly endemic regions of the 
Middle East. Recent molecular studies, however, have reported genital 
lesions caused by T. pallidum subspecies endemicum in persons from 
Cuba and Japan, and in a person with sexual contact in Pakistan.
Pinta is thought to be limited to Central America and northern 
South America, where it is found rarely and only in very remote vil­
lages. The WHO lists 15 countries in Latin America where pinta was 
previously endemic; however, due to the lack of surveillance, the cur­
rent prevalence of pinta is unknown. In the early 1980s, clinical evi­
dence of pinta was discovered in 20% of the examined inhabitants of a

TABLE 188-1  Classic Comparison of the Agents of the Human Treponematoses and Their Associated Diseases
FEATURE
SYPHILIS
YAWS
BEJEL (ENDEMIC SYPHILIS)
PINTA
Organism
T. pallidum subsp. pallidum
T. pallidum subsp. pertenue
T. pallidum subsp. endemicum
T. carateum
Common modes of 
transmission
Sexual, transplacental, skin-to-skin
Skin-to-skin
Mouth-to-mouth or via shared 
drinking/eating utensils, skin to 
skin, sexuala
Usual age of acquisition
Sexual maturity or in utero
Childhood
Early childhood, adulthooda
Late childhood
Primary lesion
Mucocutaneous ulcer (chancre)
Papilloma, often ulcerative
Mucosal papule, rarely seen
Nonulcerating papule with 
satellites, pruritic
Common location
Genital, oral, anal
Extremities
Oral, occasionally sexuala
Extremities, face
Secondary lesions
Cutaneous rash and mucosal lesions; 
condylomata lata, ocular and otic 
syphilis
Cutaneous papillomatous or 
ulcerative lesions; condylomata 
lata, osteoperiostitis
Infectious relapses
~25%
Common
Unknown
Unknown
Late complications
Gummas, cardiovascular and central 
nervous system involvement
Destructive gummas of skin, 
bone, cartilageb
Destructive gummas of skin, bone, 
cartilageb
Nondestructive, dyschromic, 
achromic macules
aSexual transmission has been recently postulated for bejel (see text). bCentral nervous system involvement and congenital infection in the endemic treponematoses have 
been postulated by some investigators (see text).
remote village in Panama. In 1987 and 1993, pinta cases were reported 
in indigenous populations living in the Amazon border region of Bra­
zil, Colombia, and Peru. More recently, in 1999, an active pinta lesion 
was identified in a Cuban tourist visiting Austria, and in 2021, a case of 
pinta was confirmed in southern Brazil. It is likely, therefore, that pinta 
is still endemic in some remote areas of Latin America.
It is important to note the vast majority of the data described for 
the endemic treponematoses are reported as “suspected cases” that are 
based on clinical diagnosis of ulcers and are not confirmed. Serologic 
confirmation is only occasionally available, and even reactive trepone­
mal serologies may reflect past or latent treponemal infection that is 
unrelated to the etiology of the ulcer. Molecular studies of lesion swabs 
from Papua New Guinea indicate that ~30% of suspected yaws lesions 
contain T. pallidum DNA; most of these had T. pallidum DNA detected 
alone, while some contained both T. pallidum and Haemophilus ducreyi 
DNA (dual infection). Approximately 50% of lesions contained DNA 
Number of reported cases, 2022
≥ 10,000
1,000 – 9,999
< 1,000
Interrupted transmission
FIGURE 188-1  Geographic distribution of yaws in 2022. (Reproduced with permission from World Health Organization.)

Skin-to-skin
Mucocutaneous lesions (mucous 
patch, split papule, condylomata 
lata); osteoperiostitis
Pintides, pigmented, pruritic
from H. ducreyi, but not T. pallidum. Data from other sites confirm 
these approximate proportions. Of the 20% of lesions that had neither 
of these pathogens identified, Streptococcus pyogenes was the most 
abundant organism detected in a metagenomic analysis. Both H. ducreyi 
and S. pyogenes have been shown to be common skin and environmen­
tal contaminants in yaws-endemic areas but may also serve as primary 
pathogens or secondary infections. Thus, the accuracy of the diagnosis 
in “yaws cases” reported to WHO is unclear.
CHAPTER 188
Evidence of yaws-like and genital lesions, with treponemal serore­
activity, has been found in several species of wild nonhuman primates 
(NHP) in sub-Saharan Africa, providing evidence that there is an ani­
mal reservoir for yaws treponemes. At the genomic level, these organ­
isms are virtually identical to known human T. pallidum subspecies 
pertenue isolates. Although direct NHP-human transmission has not 
yet been confirmed, this finding likely has important implications for 
yaws eradication efforts.
Endemic Treponematoses

Countries with suspected cases
Previously endemic countries (current status unknown)
Non-endemic countries
Not applicable

■
■MICROBIOLOGY

The etiologic agents of the endemic treponematoses are listed in 
Table 188-1. These little-studied organisms are morphologically 
identical to T. pallidum subspecies pallidum (the agent of syphilis), 
and no definitive antigenic differences among them have been identified 
to date. A controversy has existed for decades about whether the patho­
genic treponemes are truly separate organisms or represent a genetic 
continuum. Current genome sequencing indicates that, although yaws, 
bejel, and syphilis isolates clearly cluster in separate branches of phyloge­
netic trees, these organisms are 99.8% identical at the genomic level, and 
several studies support the ability of these pathogens to exchange DNA 
between subspecies. Genomic studies of many more isolates from differ­
ing geographic regions are needed to further understand the genomic 
relationship among the pathogenic treponemes to better inform nomen­
clature decisions. Currently, three of the four etiologic agents are classi­
fied as subspecies of T. pallidum; the fourth (T. carateum) remains a 
separate species simply because no pinta organisms have been available 
for genetic studies. Based on analysis of a limited number of strains and 
clinical samples available for genetic studies, molecular signatures that 
can differentiate the known strains of T. pallidum subspecies have been 
identified using approaches ranging from restriction fragment length 
polymorphism to whole genome sequencing. No obvious genetic poly­
morphisms have been identified that might be related to any distinct 
clinical characteristic of these diseases.
■
■CLINICAL FEATURES
All of the treponemal infections, including syphilis, are chronic and 
are characterized by defined disease stages, with a localized primary 
lesion, disseminated secondary lesions, periods of latency, and possible 
late lesions. Primary and secondary stages are more frequently over­
lapping in yaws and bejel than in syphilis, and the late manifestations 
of pinta are very mild relative to the destructive lesions of the other 
treponematoses. The current preference is to divide the clinical course 
of the endemic treponematoses into “early” and “late” stages, and this 
terminology is increasingly used for syphilis as well.
PART 5
Infectious Diseases
Historically, the major clinical distinctions made between syphilis 
and the other human treponematoses are the apparent lack of congenital 
transmission and of central nervous system (CNS) involvement in the 
“nonvenereal” infections. It is not known whether these distinctions 
are entirely accurate. Because of the high degree of genetic relatedness 
among the organisms, there is little biologic reason to think that T. pal­
lidum subspecies endemicum and T. pallidum subspecies pertenue would 
be unable to cross the blood–brain barrier or to invade the placenta. 
These organisms are like T. pallidum subspecies pallidum in that they 
obviously disseminate from the site of initial infection and can persist 
for decades. The lack of recognized congenital infection may be because 
childhood infections often reach the latent stage (characterized by a low 
to undetectable bacterial load) before girls reach sexual maturity, thus 
reducing the likelihood of fetal infection. Neurologic involvement may 
go unrecognized because of the lack of trained medical personnel in 
endemic regions, the delay of many years between infection and possible 
CNS manifestations, or a low rate of symptomatic CNS disease. Some 
D
C
B
A
FIGURE 188-2  Clinical manifestations of early yaws. A. Primary ulcer. B. Secondary papillomata. C. Periostitis, D. Polydactylitis. (Photos were taken during a yaws 
elimination trial in Papua New Guinea and are published with permission from Dr. Oriol Mitjà.)

published evidence supports congenital transmission as well as cardio­
vascular, ophthalmologic, and CNS involvement in yaws and endemic 
syphilis. Although the reported studies have been small, have failed to 
control for other causes of CNS abnormalities, and in some instances 
have not included serologic confirmation, it may be erroneous to accept 
unquestioningly the frequently repeated belief that these organisms fail 
to cause such manifestations.
Yaws 
Also known as pian, framboesia, or bouba, yaws is characterized 
by the development of one or several primary lesions (“mother yaw”) 
followed by multiple disseminated skin lesions. All early skin lesions 
are infectious and may persist for many months; cutaneous relapses are 
common during the first 5 years. Late manifestations, affecting ~10% of 
untreated persons, are destructive lesions of skin, bone, and joints.
The infection is transmitted by direct contact with infectious lesions, 
often during play or group sleeping, and may be enhanced by disruption 
of the skin by insect bites or abrasions. While T. pallidum subspecies 
pertenue DNA has been detected on flies and fomites from endemic 
regions, there is not yet convincing evidence of insect or fomite transmis­
sion of infection. After an average of 3–4 weeks, the first lesion begins 
as a papule—usually on an extremity—and then enlarges (particularly 
during moist warm weather) to become ulcerated (Fig 188-2A) or pap­
illomatous (“raspberry-like”—thus the name “framboesia”). Regional 
lymphadenopathy develops, and the lesion usually heals within 6 
months; dissemination is thought to occur during the early weeks of 
infection. A generalized secondary eruption, accompanied by general­
ized lymphadenopathy, appears either concurrent with or after the 
primary lesion, and may take several forms—macular, papular, or papil­
lomatous (Fig. 188-2B). Painful papillomatous lesions on the soles of the 
feet result in a crablike gait (“crab yaws”), and periostitis (Fig. 188-2C) 
may result in nocturnal bone pain and polydactylitis (Fig. 188-2D). Late 
yaws is manifested by gummas of the skin and long bones, hyperkerato­
ses of the palms and soles, osteitis and periostitis, and hydrarthrosis. The 
late gummatous lesions are characteristically extensive. Destruction of 
the nose, maxilla, palate, and pharynx is termed gangosa and is similar 
to the destructive lesions seen in leprosy and leishmaniasis.
Bejel 
The early lesions of bejel (endemic syphilis, siti, dichuchwa, 
njovera, skerljevo) are usually localized to mucocutaneous and mucosal 
surfaces. The infection is reportedly transmitted by direct contact, 
by kissing, by premastication of food, or by sharing of drinking and 
eating utensils. Recently, however, T. pallidum subspecies endemicum 
has been identified in genital lesions (clinically diagnosed as primary 
syphilitic chancres) and in secondary lesions in several settings, sug­
gesting sexual transmission. The initial lesion, usually an intraoral 
papule, may go unrecognized and is followed by mucous patches on 
the oral mucosa (Fig. 188-3A) and mucocutaneous lesions resembling 
the condylomata lata of secondary syphilis. This eruption may last for 
months or even years, and treponemes can readily be demonstrated in 
early lesions. Periostitis and regional lymphadenopathy are common. 
After a variable period of latency, late manifestations may appear, 
including osseous and cutaneous gummas. Destructive gummas, oste­
itis, and gangosa are more common in bejel than in yaws.